Journal
MUSCLE & NERVE
Volume 43, Issue 1, Pages 19-25Publisher
WILEY
DOI: 10.1002/mus.21777
Keywords
motor neuron disease; neuropathy target esterase; neurotoxicity; organophosphorus compound; paraplegia; spasticity; spinal cord disorder; Troyer syndrome
Categories
Funding
- National Institutes of Health [NINDS R01NS053917]
- Department of Veterans Affairs
- Spastic Paraplegia Foundation
- Paul and Lois Katzman Family Fund
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053917] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Recently, we reported that mutations in the neuropathy target esterase (NTE) gene cause autosomal recessive motor neuron disease (NTE-MND). We describe clinical, neurophysiologic, and neuroimaging features of affected subjects in the index families. NTE-MND subjects exhibited progressive lower extremity spastic weakness that began in childhood and was later associated with atrophy of distal leg and intrinsic hand muscles. NTE-MND resembles Troyer syndrome, except that short stature, cognitive impairment, and dysmorphic features, which often accompany Troyer syndrome, are not features of NTE-MND. Early onset, symmetry, and slow progression distinguish NTE-MND from typical amyotrophic lateral sclerosis. NTE is implicated in organophosphorus compound-induced delayed neurotoxicity (OPIDN). NTE-MND patients have upper and lower motor neuron deficits that are similar to OPIDN. Motor neuron degeneration in subjects with NTE mutations supports the role of NTE and its biochemical cascade in the molecular pathogenesis of OPIDN and possibly other degenerative neurologic disorders. Muscle Nerve 43: 19-25, 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available